Press Releases
Search
-
17 Oct 2016
Lyme disease diagnostic tests
Like other laboratories, bioMérieux has been summoned to appear before the Tribunal de Grande Instance de Paris by 45 patients to obtain compensations linked to anxiety allegedly “generated by a lack ...
-
11 Oct 2016
FilmArray® Respiratory Panel EZ is CLIA waived by the FDA
bioMérieux, a world leader in the field of in vitro diagnostics, announced that BioFire Diagnostics, LLC, its molecular biology affiliate, received U.S. Food and Drug Administration (FDA) 510(k) clear...
-
10 Oct 2016
BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi join forces against sepsis
BIOASTER, the French accelerator of microbiology technology innovation, bioMérieux, ESPCI (College of Physics and Industrial Chemistry of the city of Paris), GSK, the Hospices Civils de Lyon (HCL) and...
-
06 Oct 2016
bioMérieux introduces EviSight™ Compact, a new automated diagnostic solution for microbial detection in pharmaceutical production
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of EviSight™ Compact, an intelligent incubator system providing real time culture media reading. For...
-
31 Aug 2016
bioMérieux – First-Half 2016 Results
Strong growth in sales, up 10.9% at constant exchange rates and scope of consolidation: €1,001 million in sales Up 7.2% as reported Sharp 22% improvement in contributive operating income before non-re...
-
18 Jul 2016
bioMérieux – Second-Quarter 2016 Business Review
Strong growth in sales, up 10.9%, at constant exchange rates and scope of consolidation in the first half of 2016: Sales reached €1,001 million Up 7.2% as reported Growth continued to be led by the Am...